基本信息
views: 6
Career Trajectory
Bio
Dr. Robinson has a multi-protein clade B DNA/MVA vaccine regimen in clinical trials through the US HIV vaccine Trials Network (HVTN). The vaccine was developed in Dr. Robinson's former laboratory at the Emory Vaccine Center in collaboration with Dr. Bernard Moss's laboratory at the US NIH.
Research Interests
Papers共 188 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kelly E. Seaton,Aaron Deal,Xue Han,Shuying S. Li,Ashley Clayton,Jack Heptinstall,Ann Duerr,Mary A. Allen,Xiaoying Shen,Sheetal Sawant,Nicole L. Yates,Paul Spearman,Gavin Churchyard,Paul A. Goepfert,Janine Maenza,Glenda Gray,Giuseppe Pantaleo,Laura Polakowski,Harriet L. Robinson,Shannon Grant,April K. Randhawa,Ying Huang,Cecilia Morgan,Nicole Grunenberg,Shelly Karuna,Peter B. Gilbert, M. Juliana McElrath,Yunda Huang,Georgia D. Tomaras
Yunda Huang,Kelly E. Seaton,Martin Casapia,Laura Polakowski,Stephen C. De Rosa,Kristen Cohen,Chenchen Yu,Marnie Elizaga, Carmen Paez,Maurine D. Miner,Colleen F. Kelley,Janine Maenza,Michael Keefer,Javier R. Lama,Magdalena Sobieszczyk,Susan Buchbinder,Lindsey R. Badenj,Carter Lee, Vineeta Gulati,Faruk Sinangil,David Montefiori,M. Juliana McElrath,Georgia D. Tomaras,Harriet L. Robinsonm,Paul Goepfert
Vaccineno. 33 (2021): 4641-4650
SCIENTIFIC REPORTSno. 1 (2020)
H. L. Robinson, R. Basu,J. A. Schwartz, M. J. Hauser,C. T. Demarco,A. L. DeVico, B. F. Haynes, H. Andersen
Cited2Views0Bibtex
2
0
Clinical Pharmacology & Therapeuticsno. 6 (2018): 1062-1073
Cited0Views0Bibtex
0
0
Cited0Views0Bibtex
0
0
Clinical Pharmacology & Therapeuticsno. 6 (2018): 1062-1073
Load More
Author Statistics
#Papers: 188
#Citation: 10405
H-Index: 52
G-Index: 100
Sociability: 7
Diversity: 3
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn